Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$13.6K Sell
74
-6
-8% -$1.11K 0.01% 244
2025
Q4
$14.1K Sell
80
-9
-10% -$1.47K 0.01% 241
2025
Q3
$12.5K Hold
89
0.01% 248
2025
Q2
$11.2K Buy
89
+76
+585% +$9.47K 0.01% 250
2025
Q1
$1.78K Sell
13
-35
-73% -$5K ﹤0.01% 530
2024
Q4
$7.34K Buy
48
+20
+71% +$3.37K ﹤0.01% 298
2024
Q3
$5.43K Hold
28
﹤0.01% 345
2024
Q2
$6.49K Buy
+28
New +$6.08K ﹤0.01% 311
2023
Q1
Sell
-7
Closed -$1.94K 564
2022
Q4
$1.94K Buy
+7
New +$1.98K ﹤0.01% 476

Other funds holding BIIB

Red Tortoise LLC's BIIB Position: Q1 2026 in Review

Red Tortoise LLC reduced its Biogen (BIIB) stake by 7.5% in Q1 2026, selling an estimated $1.11K and leaving 74 shares worth $13.6K. The position accounts for 0.01% of the portfolio, ranked #244.

Red Tortoise LLC first reported a position in BIIB in Q4 2022 and has held it in 9 quarters since. The position peaked at $14.1K in Q4 2025. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

  • Red Tortoise LLC held 74 shares of Biogen worth $13.6K as of Q1 2026.
  • Red Tortoise LLC sold 6 Biogen shares in Q1 2026, an estimated $1.11K.
  • Biogen made up 0.01% of Red Tortoise LLC's portfolio in Q1 2026, its #244 holding.
  • Red Tortoise LLC first reported a position in Biogen in Q4 2022 and has held it in 9 quarters since.
  • Red Tortoise LLC's Biogen position peaked at $14.1K in Q4 2025.
  • 1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on Red Tortoise LLC's 13F filing for Q1 2026, filed 21 Apr 2026.